Michael Wilmink, Director at Eupraxia Pharmaceuticals, holds 219.43K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX). Most recently, Michael Wilmink Bought C$2,857 shares of Eupraxia Pharmaceuticals on Aug 21, 2023 for an estimated value of 20.00K.